2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | - | - | - | - | 8.429 | 7.168 | 20.312 | 10.416 | 3.515 | 698 |
Total Income - EUR | - | - | - | - | 8.429 | 7.168 | 20.312 | 10.440 | 3.783 | 12.292 |
Total Expenses - EUR | - | - | - | - | 7.531 | 5.246 | 18.993 | 13.242 | 16.104 | 9.549 |
Gross Profit/Loss - EUR | - | - | - | - | 898 | 1.922 | 1.318 | -2.802 | -12.321 | 2.743 |
Net Profit/Loss - EUR | - | - | - | - | 645 | 1.707 | 541 | -3.115 | -12.825 | 2.110 |
Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Belarco Pharm S.r.l.
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | - | - | - | - | 0 | 7.021 | 8.736 | 4.022 | 970 | 12.032 |
Current Assets | - | - | - | - | 6.394 | 5.967 | 8.840 | 19.254 | 10.317 | 21.149 |
Inventories | - | - | - | - | 185 | 72 | 122 | 1.695 | 209 | 208 |
Receivables | - | - | - | - | 52 | 215 | 1.261 | 9.655 | 3.265 | 14.805 |
Cash | - | - | - | - | 6.158 | 5.680 | 7.457 | 7.905 | 6.843 | 6.136 |
Shareholders Funds | - | - | - | - | 688 | 2.382 | 2.877 | -301 | -13.127 | 7.103 |
Social Capital | - | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | - | - | - | - | 2.644 | 8.712 | 13.311 | 10.196 | 19.440 | 21.117 |
Income in Advance | - | - | - | - | 3.062 | 3.003 | 4.786 | 15.769 | 7.371 | 7.348 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4646 - 4646" | |||||||||
CAEN Financial Year |
4646
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Belarco Pharm S.r.l.